178 related articles for article (PubMed ID: 17923240)
1. Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine A.
Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Rzasa RM; Shea HA; Li S; Park K; Ma G; Romo D; Liu JO
Methods Enzymol; 2007; 431():303-24. PubMed ID: 17923240
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A.
Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Merrick WC; Romo D; Liu JO
Mol Cell; 2005 Dec; 20(5):709-22. PubMed ID: 16337595
[TBL] [Abstract][Full Text] [Related]
3. Stopping trouble before it starts.
Clardy J
ACS Chem Biol; 2006 Feb; 1(1):17-9. PubMed ID: 17163634
[TBL] [Abstract][Full Text] [Related]
4. Substrate-dependent targeting of eukaryotic translation initiation factor 4A by pateamine A: negation of domain-linker regulation of activity.
Low WK; Dang Y; Bhat S; Romo D; Liu JO
Chem Biol; 2007 Jun; 14(6):715-27. PubMed ID: 17584618
[TBL] [Abstract][Full Text] [Related]
5. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
Bordeleau ME; Cencic R; Lindqvist L; Oberer M; Northcote P; Wagner G; Pelletier J
Chem Biol; 2006 Dec; 13(12):1287-95. PubMed ID: 17185224
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the mechanism of action of a potent pateamine A analog, des-methyl, des-amino pateamine A (DMDAPatA).
Kommaraju SS; Aulicino J; Gobbooru S; Li J; Zhu M; Romo D; Low WK
Biochem Cell Biol; 2020 Aug; 98(4):502-510. PubMed ID: 32008367
[TBL] [Abstract][Full Text] [Related]
7. Evidence for separate binding and scaffolding domains in the immunosuppressive and antitumor marine natural product, pateamine a: design, synthesis, and activity studies leading to a potent simplified derivative.
Romo D; Choi NS; Li S; Buchler I; Shi Z; Liu JO
J Am Chem Soc; 2004 Sep; 126(34):10582-8. PubMed ID: 15327314
[TBL] [Abstract][Full Text] [Related]
8. Functional mimicry revealed by the crystal structure of an eIF4A:RNA complex bound to the interfacial inhibitor, desmethyl pateamine A.
Naineni SK; Liang J; Hull K; Cencic R; Zhu M; Northcote P; Teesdale-Spittle P; Romo D; Nagar B; Pelletier J
Cell Chem Biol; 2021 Jun; 28(6):825-834.e6. PubMed ID: 33412110
[TBL] [Abstract][Full Text] [Related]
9. Stress Granule-Inducing Eukaryotic Translation Initiation Factor 4A Inhibitors Block Influenza A Virus Replication.
Slaine PD; Kleer M; Smith NK; Khaperskyy DA; McCormick C
Viruses; 2017 Dec; 9(12):. PubMed ID: 29258238
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of translation targeting eukaryotic translation initiation factor 4A.
Cencic R; Galicia-Vázquez G; Pelletier J
Methods Enzymol; 2012; 511():437-61. PubMed ID: 22713332
[TBL] [Abstract][Full Text] [Related]
11. Translational dysregulation by Pateamine A.
Korneeva NL
Chem Biol; 2007 Jan; 14(1):5-7. PubMed ID: 17254945
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of translation initiation as cancer therapeutics.
Lindqvist L; Pelletier J
Future Med Chem; 2009 Dec; 1(9):1709-22. PubMed ID: 21425987
[TBL] [Abstract][Full Text] [Related]
13. Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A.
Kuznetsov G; Xu Q; Rudolph-Owen L; Tendyke K; Liu J; Towle M; Zhao N; Marsh J; Agoulnik S; Twine N; Parent L; Chen Z; Shie JL; Jiang Y; Zhang H; Du H; Boivin R; Wang Y; Romo D; Littlefield BA
Mol Cancer Ther; 2009 May; 8(5):1250-60. PubMed ID: 19417157
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.
Bordeleau ME; Matthews J; Wojnar JM; Lindqvist L; Novac O; Jankowsky E; Sonenberg N; Northcote P; Teesdale-Spittle P; Pelletier J
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10460-5. PubMed ID: 16030146
[TBL] [Abstract][Full Text] [Related]
15. Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia.
Chen R; Zhu M; Chaudhari RR; Robles O; Chen Y; Skillern W; Qin Q; Wierda WG; Zhang S; Hull KG; Romo D; Plunkett W
Leukemia; 2019 Jul; 33(7):1663-1674. PubMed ID: 30700841
[TBL] [Abstract][Full Text] [Related]
16. The cellular target specificity of pateamine A.
Matthews JH; Maass DR; Northcote PT; Atkinson PH; Teesdale-Spittle PH
Z Naturforsch C J Biosci; 2013; 68(9-10):406-15. PubMed ID: 24459774
[TBL] [Abstract][Full Text] [Related]
17. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
Shen L; Pelletier J
Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A.
Dang Y; Kedersha N; Low WK; Romo D; Gorospe M; Kaufman R; Anderson P; Liu JO
J Biol Chem; 2006 Oct; 281(43):32870-8. PubMed ID: 16951406
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nonsense-mediated mRNA decay by the natural product pateamine A through eukaryotic initiation factor 4AIII.
Dang Y; Low WK; Xu J; Gehring NH; Dietz HC; Romo D; Liu JO
J Biol Chem; 2009 Aug; 284(35):23613-21. PubMed ID: 19570977
[TBL] [Abstract][Full Text] [Related]
20. eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways.
Cramer Z; Sadek J; Vazquez GG; Di Marco S; Pause A; Pelletier J; Gallouzi IE
Sci Rep; 2018 May; 8(1):8414. PubMed ID: 29849089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
